1. All Events

  2. Shares Investor Evening (Manchester) -

Shares Investor Evening (Manchester)

Presenting

ANGLE (AGL)

ANGLE (AGL)

ANGLE Plc (AGL) is a world-leading liquid biopsy company commercialising a platform technology that can capture cells circulating in blood, such as CTCs, intact living cancer cells, even when they are as rare in number as one cell in one billion blood cells, and harvest the cells for analysis. ANGLE’s cell separation technology is called the Parsortix system and is the subject of granted patents in multiple jurisdictions. The system is based on a microfluidic device that captures cells based on a combination of their size and compressibility.

Cadence Minerals (KDNC)

Cadence Minerals (KDNC)

Cadence is dedicated to smart investments for a greener world. The planet needs rechargeable batteries on a global scale – upcoming supersized passenger vehicles, lorries and buses – require lithium and other technology minerals to power their cells. Cadence is helping find these minerals in new places and extracting them in new ways, which will meet the demand of this burgeoning market. With over £20 million vested in key assets globally, Cadence is helping us reach tomorrow, today.

First Sentinel

First Sentinel

First Sentinel is a consortium of companies focused on alternative investments, specializing in equity and debt deals with appealing IRRs, as well as traditional Corporate Finance and Legal Services.

This consortium enables us to support our clients end to end, whether it be the individual investor or corporate offering.

First Sentinel PLC (NEX: FSEN) is an alternative investment company that provides growth capital for public and private company investments. (NEX: FSEN).

 

Plutus PowerGen (PPG)

Plutus PowerGen (PPG)

Plutus PowerGen is a profitable AIM listed company that is constructing flexible generation and gas powered projects in the UK. It has identified multiple revenue streams and each site is relatively low cost to deliver.
 
Plutus PowerGen has six operating projects across the UK with a further 400MW of sites under development. Since the introduction of intermittent, renewable power to the UK’s power generation mix, the National Grid is facing increasing instability and risk of brownouts and blackouts. Therefore a reliable source of power is required during periods of peak electricity demand and Plutus PowerGen’s projects can be turned on rapidly and remotely to address this requirement. Importantly, the Company has received an offer from a leading ‘Big Six’ multinational utility company to fund up to 20% of any 20MW renewable fuel or gas powered flexible energy projects going forward.
 
 
SkinBioTherapeutics (SBTX)

SkinBioTherapeutics (SBTX)

SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CEO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.

The SkinBioTherapeutics’ platform applies research discoveries made on the activities of lysates derived from probiotic bacteria when applied to skin. The Company has shown that the SkinBiotix® platform can improve the barrier effect of skin models, improve repair and reduce bacterial load.

SkinBioTherapeutics is targeting three specific skin healthcare sectors; cosmetics, infection control and eczema. In each of these areas SkinBioTherapeutics plans to exemplify its technology in human studies. The most advanced programme is focused on the application of the Skinbiotix® platform in managing sensitive skin in the cosmetics industry. The business strategy is to partner and outlicense its programmes at proof of concept.

Register Now